These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 28328856

  • 1. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
    Li XL, Wang L, Lv F, Huang XM, Wang LP, Pan Y, Zhang XM.
    Medicine (Baltimore); 2017 Mar; 96(12):e6443. PubMed ID: 28328856
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials.
    Yang P, Wu R, Zhang H.
    Reprod Biol Endocrinol; 2020 Jul 29; 18(1):76. PubMed ID: 32727608
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K, Kogan I, Krikheli I, Dzhemlikhanova L, Muller V, Mekina I, Lesik E, Komarova E, Mazilina M, Niauri D, Gzgzyan A, Aylamazyan E.
    Gynecol Endocrinol; 2017 Jul 29; 33(sup1):15-17. PubMed ID: 29264990
    [Abstract] [Full Text] [Related]

  • 7. Administration of growth hormone improves endometrial function in women undergoing in vitro fertilization: a systematic review and meta-analysis.
    Shang Y, Wu M, He R, Ye Y, Sun X.
    Hum Reprod Update; 2022 Nov 02; 28(6):838-857. PubMed ID: 35641113
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, van Wely M.
    Cochrane Database Syst Rev; 2010 Nov 10; (11):CD008046. PubMed ID: 21069701
    [Abstract] [Full Text] [Related]

  • 11. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M.
    Cochrane Database Syst Rev; 2011 Jan 19; (1):CD008046. PubMed ID: 21249699
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders.
    Skillern A, Leonard W, Pike J, Mak W.
    J Assist Reprod Genet; 2021 May 19; 38(5):1055-1060. PubMed ID: 33534048
    [Abstract] [Full Text] [Related]

  • 13. Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial.
    Li J, Chen Q, Wang J, Huang G, Ye H.
    BMC Pregnancy Childbirth; 2020 May 20; 20(1):310. PubMed ID: 32434490
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov 20; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 16. Ovarian stimulation for freeze-all IVF cycles: a systematic review.
    Mizrachi Y, Horowitz E, Farhi J, Raziel A, Weissman A.
    Hum Reprod Update; 2020 Jan 01; 26(1):118-135. PubMed ID: 31867625
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov 01; 48(11):838-42. PubMed ID: 24444561
    [Abstract] [Full Text] [Related]

  • 19. Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis.
    Lin G, Zhong X, Li S, Xu L.
    Front Endocrinol (Lausanne); 2023 Nov 01; 14():1215755. PubMed ID: 38027219
    [Abstract] [Full Text] [Related]

  • 20. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
    Roustan A, Perrin J, Debals-Gonthier M, Paulmyer-Lacroix O, Agostini A, Courbiere B.
    Hum Reprod; 2015 Apr 01; 30(4):840-7. PubMed ID: 25740883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.